The University of Washington Tuberculosis Research & Training Center (TRTC) held its fourth annual Tuberculosis Symposium on September 16, 2019. Over 100 researchers from UW, Seattle Children’s Research Institute, Stanford University, IHME, and others participated in the symposium. The Symposium, entitled “Innovations to help end the TB epidemic; a new vision for the 21st century,” featured sessions on TB vaccines, the risk of TB disease in children, and TB control interventions, and showcased innovations to help end the TB epidemic, both locally and globally.

The University of Washington’s School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy. This interdisciplinary project will explore ways in which community pharmacists can better support people living with this neurological disorder.

The roughly 3.4 million people nationally and 75,000 people in Washington state who live with epilepsy often get fragmented and uncoordinated healthcare and community services.

As part of the Ending the HIV Epidemic (EHE): A Plan for America initiative, the University of Washington/Fred Hutch Center for AIDS Research (CFAR) received $1.2 million to fund five research projects. This initiative allocates funding to HIV research with the goal of reducing new infections in the United States by 90 percent by 2030.

Gabrielle O’Malley, an Associate Professor of Global Health and Director of Implementation Science for the International Training and Education Center (I-TECH), received a $4,394,756 award to continue strengthening human resources for health in Malawi for HIV epidemic control and improved health outcomes of people living with HIV (PLHIV).